These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23222785)

  • 1. What's fueling the biotech engine-2011 to 2012.
    Aggarwal SR
    Nat Biotechnol; 2012 Dec; 30(12):1191-7. PubMed ID: 23222785
    [No Abstract]   [Full Text] [Related]  

  • 2. What's fueling the biotech engine-2009-2010.
    Aggarwal S
    Nat Biotechnol; 2010 Nov; 28(11):1165-71. PubMed ID: 21057482
    [No Abstract]   [Full Text] [Related]  

  • 3. What's fueling the biotech engine--2010 to 2011.
    Aggarwal S
    Nat Biotechnol; 2011 Dec; 29(12):1083-9. PubMed ID: 22158359
    [No Abstract]   [Full Text] [Related]  

  • 4. What's fueling the biotech engine-2007.
    Aggarwal S
    Nat Biotechnol; 2008 Nov; 26(11):1227-33. PubMed ID: 18997759
    [No Abstract]   [Full Text] [Related]  

  • 5. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 6. What's fueling the biotech engine-2012 to 2013.
    Aggarwal RS
    Nat Biotechnol; 2014 Jan; 32(1):32-9. PubMed ID: 24406926
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech firms jump on SARS bandwagon.
    Basu P
    Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
    [No Abstract]   [Full Text] [Related]  

  • 8. What's fueling the biotech engine--2008.
    Aggarwal S
    Nat Biotechnol; 2009 Nov; 27(11):987-93. PubMed ID: 19898448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The next generation?
    Nat Biotechnol; 2006 Nov; 24(11):1300. PubMed ID: 17093454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's hot in biotech employment.
    Hochberg SP
    Nat Biotechnol; 2001 Apr; 19(4):389. PubMed ID: 11283604
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech pharmaceuticals and biotherapy: an overview.
    Steinberg FM; Raso J
    J Pharm Pharm Sci; 1998; 1(2):48-59. PubMed ID: 10945918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 13. The business of making vaccines.
    Sheridan C
    Nat Biotechnol; 2005 Nov; 23(11):1359-66. PubMed ID: 16273061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK biotech sector loses flagship PowderJect to Chiron.
    Mitchell P
    Nat Biotechnol; 2003 Jul; 21(7):717. PubMed ID: 12833073
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech equities heat up in 1Q12.
    Yang W
    Nat Biotechnol; 2012 May; 30(5):384. PubMed ID: 22565955
    [No Abstract]   [Full Text] [Related]  

  • 16. The return of the biotech scorecard.
    Jacobs T
    Nat Biotechnol; 2006 Jul; 24(7):768. PubMed ID: 16841056
    [No Abstract]   [Full Text] [Related]  

  • 17. The shrinking biotech bazaar.
    Nat Biotechnol; 2019 Feb; 37(2):107. PubMed ID: 30718865
    [No Abstract]   [Full Text] [Related]  

  • 18. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech rallies in Q3.
    Yang W
    Nat Biotechnol; 2010 Nov; 28(11):1144. PubMed ID: 21057476
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
    Gruber AC
    Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.